Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07736521) titled 'Arthrocentesis Versus Botulinum Toxin Injection in Patients With Temporomandibular Joint Disorders: A Randomized Controlled Trial' on July 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Mudher MB Alsunbuli
Condition:
Temporomandibular Joint Disorders
Temporomandibular Joint Dysfunction Syndrome
Facial Pain
Intervention:
Procedure: Arthrocentesis
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 15, 2026
Target Sample Size: 66
To kno...